This is a revised edition of an established text on hypertension, which takes into account changes in the culture of general practice arising from the 1990 GP Contract.

Michael Yapko’s seminal 1992 book, Hypnosis and the Treatment of Depressions, was the first book ever written on the subject of applying hypnosis in the treatment of depressed individuals. Since its publication, Yapko’s work has not only withstood the test of colleagues previously dismissive of the merits of hypnosis as a tool of treatment, but has thrived in the face of it. Hypnosis and Treating Depression diversifies the range of topics to consider and increases the number of knowledgeable contributors on the subject of treating depression with hypnosis. The book features chapter contributions by highly experienced and well-known experts on using hypnosis to treat specific forms of depression, with assessment and intervention strategies as well as sample transcripts of the use of hypnosis in therapy sessions. It discusses both broad and targeted applications of hypnosis in treatment, the treatment of depression with hypnosis in special populations, as well as special considerations regarding hypnotic treatment. As a practical guidebook for clinicians looking to add to their treatment protocols, Hypnosis and Treating Depression: Applications in Clinical Practice provides an updated and comprehensive volume on therapeutic uses of hypnosis in the treatment of depression.

This book is a practical and authoritative guide to diagnosis and treatment of child and adolescent depression in various clinical settings, health care systems, and cultures. Emphasis is placed on evidence-based precepts for treatment. The contributors address current controversies surrounding the potential risks of medications in children and discuss other biological treatments and psychotherapies. Key take-home points are listed at the end of each chapter. Flow charts and tables summarize treatment recommendations, and tables summarize evidence of effectiveness and quality of evidence. Also included are lists of other resources for clinicians, patients, and families.

This is the second edition of a very successful title from an international team of highly respected opinion leaders. Its emphasis remains on how the clinical guidelines are to be interpreted effectively in everyday practice, and as such it has immense practical importance for clinical psychiatrists as an immediate source of reference. New to this

Delivers the Evidence-Based Gold-Standard EMDR Protocol for Ameliorating Depression This groundbreaking book introduces EMDR-DeprEnd, a pathogenic memory-based EMDR therapy approach. DeprEnd has been demonstrated in a number of studies and meta-analyses to be at least as effective—and often more effective—than other guideline-based therapies in treating depression, including cognitive behavioral therapy (CBT). EMDR-DeprEnd is particularly helpful with chronic and recurrent depression that does not respond well to other treatments. Written by the international research team who developed this quick-acting and efficient therapy, the text provides clinicians with the evidence-based tools they need to integrate EMDR-DeprEnd into their practices. This text explains in depth a step-by-step approach to processing the pathogenic memory structures that are the basis of most depressive disorders and ways to address both depressive and suicidal states. Real-world case studies incorporate the often-co-occurring trauma-based disorders found in depressive patients. These are practical “how-to” chapters, including one devoted to drawing integration with numerous examples of actual patient drawings as clients go through the EMDR process. Abundant illustrations enhance understanding of stress and trauma-based depressive disorders and the successful interventions that improve client outcomes. Protocol scripts for therapist and client also help prepare readers to provide optimal treatment to their clients. Key Features: Authored by the international research team who developed this touchstone EMDR therapy treatment Helps with chronic and recurrent depression especially if it is resistant to guideline-based treatments, including CBT Demonstrates step-by-step how to apply the DeprEnd protocol using real-world case examples Describes how EMDR’s neurobiological working mechanism effectively treats depression Includes protocol scripts and a review of randomized controlled trials related to EMDR and depression Illustrates how DeprEnd protocol reduces depressive relapses

A philosopher argues there is an ethical imperative to provide psychotherapy to depressed patients because the insights gained from it promote autonomy. One in six people worldwide will experience depression over the course of a lifetime. Many who seek relief through the healthcare system are treated with antidepressant medication; in the United States, nearly 170 million prescriptions for antidepressants were written in 2005, resulting in more than $12 billion in sales. And yet despite the dominance of antidepressants in the marketplace and the consulting room, another treatment for depression has proven equally effective: psychotherapy—in particular, cognitive behavior therapy (CBT). Antidepressants can lift mood independent of a person's understanding of symptoms or stressors. By contrast, CBT teaches patients skills for dealing with distressing feelings, negative thoughts, and causal stressors. In The Ethical Treatment of Depression, Paul Biegler argues that the insights patients gain from the therapeutic process promote autonomy. He shows that depression is a disorder in which autonomy is routinely and extensively undermined and that physicians have a moral obligation to promote the autonomy of depressed patients. He concludes that medical practitioners have an ethical imperative to prescribe psychotherapy—CBT in particular—for depression. To make his case, Biegler draws on a wide philosophical literature relevant to autonomy and the emotions and makes a comprehensive survey of the latest research findings from the psychological sciences. Forcefully argued, densely researched, and engagingly written, the book issues a challenge to physicians who believe their duty of care to depressed patients is discharged by merely writing prescriptions for antidepressants.

Depression is a debilitating human condition and a common cause of suffering worldwide. This elicits a sense of urgency for mental health professionals to meet this challenge of the treatment of depression. Hypnosis plays a vital role in that treatment and in the efficacy of psychotherapy. This book focuses on the structuring and delivering of hypnotic interventions for major depression, with a substantial use of concepts and techniques from cognitive-behavioral and strategic approaches as a foundation. Current research on depression is used in this book to emphasize the still-growing knowledge of depression. Hypnosis has shown itself to be effective in not only reducing symptoms, but in teaching the skills (such as rationale thinking, effective problem-solving and coping strategies, and positive relationship skills) that can even prevent recurrences. Mental health professionals will find the detailed examples of hypnotic strategies invaluable to their own practice and application of hypnosis in the treatment of depression.

Offers mental health professionals a viable solution to the dilemma that managed care systems require them to treat long- term depression in a set amount of time. Reviews managed care, brief therapy, and theories of depression, then considers assessment, diagnosis, treatment options for major depression and less severe mood disorders, children and the elderly, and special problems. Annotation copyrighted by Book News, Inc., Portland, OR

Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. - Defines Treatment-Resistant Depression and Staging Treatment Intensity - Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions - Discusses the use of Ketamine and Esketamine for treatment-resistant depression

This concise, well-organized volume answers common questions about depression and available treatment techniques for people being treated for depression, those considering treatment, their families and friends, and practitioners. Written in an easy-to-follow question-and-answer format, this book walks the reader through the maze of the latest information available on this far-reaching medical problem. The authors present detailed analyses of the effectiveness of all available treatments -- from psychotherapy to medicine to exercise.